Study on belapectin (gr-md-02) in patients with Nash Cirrhosis (H-48211)
Description
Content
Seamless, adaptive, phase 2b/3, double-blind, randomized, placebo-controlled, multicenter, international study evaluating the efficacy and safety of belapectin (gr-md-02) for the prevention of esophageal varices in Nash Cirrhosis
Contact
Phone 1: 713–798–1037
IRB: H-48211
Status:
Active
Created:
